Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 3
Encontrada(s) 1 página(s)

RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Development of Bioactive Patch for Maintenance of Implanted Cells at the Myocardial Infarcted Site

  • Castells-Sala, C.
  • Soler-Botija, C.
  • Arnal Pastor, María Pilar
  • Fernandez-Muinos, T.
  • Mari-Buye, N.
  • Llucia-Valldeperas, A.
  • Sanchez, B.
  • Chachques, J. C.
  • Bayes-Genis, A.
  • Semino, C. E.
  • Vallés Lluch, Ana|||0000-0002-7896-8666
  • Martínez-Ramos, Cristina|||0000-0002-6540-4714
  • Monleón Pradas, Manuel|||0000-0001-6457-0414
[EN] Ischemia produced as a result of myocardial infarction might cause moderate or severe tissue death. Studies under development propose grafting stem cells into the affected area and we hypothesize that this mechanism could be enhanced by the application of a "bioactive implant." The implant herein proposed consists of a thin porous elastomeric membrane, filled with self-assembling nanofibers and human subcutaneous adipose tissue derived progenitor cells. We describe the development and characterization of two elastomeric membranes: poly(ethyl acrylate) (PEA) and poly(caprolactone 2-(methacryloyloxy) ethyl ester) (PCLMA). Both are a good material support to deliver cells within a soft self-assembling peptide and are elastic enough to withstand the stresses arising from the heartbeat. Both developed composites (PEA and PCLMA, combined with self-assembling peptide) equally facilitate the propagation of electrical pulses and maintain their genetic profile of the seeded cells. Preliminary studies with small animal models suggest that, at short times, the bioimplant shows good adhesion with the myocardium. After three days cells loaded in the patch remain alive at the implanted site. We propose that the bioactive patch (elastomeric membranes with self-assembling peptide and cells) could increase the efficacy of future cardiac cell therapy by improving cell immobilization and survival at the affected site., The authors wish to thank the Department of Cardiac Surgery (Hospital Germans Trias i Pujol, Badalona) for their collaboration in obtaining human samples, Dr. Bago for his kind contribution in the cell transduction process and BLI analysis, and Joan Gilabert from Biomaterials Laboratory (GEMAT, IQS-School of Engineering) who kindly helped them with wettability measurements. The research leading to these results has received funding from the European Union Seventh Framework Programme (FP7/2007-2013) under Grant agreement no. 229239. This work was also supported by Grants from Ministerio de Educacion y Ciencia (SAF2011-30067-C02-01 and M. Arnal-Pastor FPU 2009-1870 grant), Red de Terapia Celular-TerCel (RD12/0019/0029), Red Cardio-vascular (RD12/0042/0047), and Fundacio La Marato de TV3 (122232).
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Topologically controlled hyaluronan-based gel coatings of hydrophobic grid-like scaffolds to modulate drug delivery

  • Arnal Pastor, María Pilar
  • Perez Garnes, Manuel
  • Monleón Pradas, Manuel|||0000-0001-6457-0414
  • Vallés Lluch, Ana|||0000-0002-7896-8666
[EN] Scaffolds based on poly(ethyl acrylate) having interwoven channels were coated with a hyaluronan (HA) hydrogel to be used in tissue engineering applications. Controlled typologies of coatings evolving from isolated aggregates to continuous layers, which eventually clog the channels, were obtained by using hyaluronan solutions of different concentrations. The efficiency of the HA loading was determined using gravimetric and thermogravimetric methods, and the hydrogel loss during the subsequent crosslinking process was quantified, seeming to depend on the mass fraction of hyaluronan initially incorporated to the pores. The effect of the topologically different coatings on the scaffolds, in terms of mechanical properties and swelling at equilibrium under different conditions was evaluated and correlated with the hyaluronan mass fraction. The potential of these hydrogel coatings as vehicle for controlled drug release from the scaffolds was validated using a protein model., The authors acknowledge the financing through projects FP7 NMP3-SL-2009-229239 (RECATABI) and MAT2011-28791-C03-02 and -03. This work was also supported by the Spanish Ministry of Education through M. Arnal-Pastor FPU2009-1870 and M. Perez-Garnes BES-2009-015314 grants.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Hydrophilic surface modification of acrylate-based biomaterials

  • Arnal Pastor, María Pilar
  • Comín-Cebrián, S.
  • Martínez-Ramos, C.
  • Monleón Pradas, Manuel|||0000-0001-6457-0414
  • Vallés Lluch, Ana|||0000-0002-7896-8666
[EN] Acrylic polymers have proved to be excellent with regard to cell adhesion, colonization and survival, in vitro and in vivo. Highly ordered and regular pore structures thereof can be produced with the help of polyamide templates, which are removed with nitric acid. This treatment converts a fraction of the ethyl acrylate side groups into acrylic acid, turning poly(ethyl acrylate) scaffolds into a more hydrophilic and pH-sensitive substrate, while its good biological performance remains intact. To quantify the extent of such a modification, and be able to characterize the degree of hydrophilicity of poly(ethyl acrylate), poly(ethyl acrylate) was treated with acid for different times (four, nine and 17 days), and compared with poly(acrylic acid) and a 90/10%wt. EA/AAc copolymer (P(EA-co-AAc)). The biological performance was also assessed for samples immersed in acid up to four days and the copolymer, and it was found that the incorporation of acidic units on the material surface was not prejudicial for cells. This surface modification of 3D porous hydrophobic scaffolds makes easier the wetting with culture medium and aqueous solutions in general, and thus represents an advantage in the manageability of the scaffolds., The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: The authors acknowledge financing through project FP7 NMP3-SL-2009-229239 'Regeneration of cardiac tissue assisted by bioactive implants' (RECATABI) and projects MAT2011-28791-C03-02 and -03 from the Spanish Ministerio de Ciencia e Innovacion. This work was also supported by the Spanish Ministry of Education through M. Arnal-Pastor FPU AP2009-1870 grant.